Pharmaceutical products; requiring manufacturers to publish certain list of ingredients; providing administrative, civil, and criminal penalties and remedies. Effective date.

SB 941 requires all pharmaceutical manufacturers selling products in Oklahoma - including prescription drugs, over-the-counter medications, vaccines, and research products - to publicly disclose detailed ingredient lists. This includes active/inactive components, biological sources (like mRNA or animal-derived materials), synthetic elements (such as lipids or nanotech), and exact quantities for each product. Manufacturers must submit this information to the State Board of Pharmacy, publish it on their websites, and include it in product labeling, with penalties for noncompliance including fines up to $250,000 per violation or criminal charges for intentional misrepresentation. The law takes effect January 1, 2026, and overrides conflicting state rules.